Logo image of PLAB

PHOTRONICS INC (PLAB) Stock Fundamental Analysis

USA - NASDAQ:PLAB - US7194051022 - Common Stock

23.5 USD
+0.36 (+1.56%)
Last: 10/15/2025, 6:56:15 PM
23.45 USD
-0.05 (-0.21%)
After Hours: 10/15/2025, 6:56:15 PM
Fundamental Rating

6

PLAB gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 112 industry peers in the Semiconductors & Semiconductor Equipment industry. PLAB has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. PLAB is valued quite cheap, while showing a decent growth score. This is a good combination! With these ratings, PLAB could be worth investigating further for value investing!.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year PLAB was profitable.
PLAB had a positive operating cash flow in the past year.
Each year in the past 5 years PLAB has been profitable.
Each year in the past 5 years PLAB had a positive operating cash flow.
PLAB Yearly Net Income VS EBIT VS OCF VS FCFPLAB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M

1.2 Ratios

PLAB has a Return On Assets of 6.19%. This is in the better half of the industry: PLAB outperforms 74.11% of its industry peers.
PLAB's Return On Equity of 9.64% is fine compared to the rest of the industry. PLAB outperforms 71.43% of its industry peers.
Looking at the Return On Invested Capital, with a value of 9.95%, PLAB is in the better half of the industry, outperforming 78.57% of the companies in the same industry.
PLAB had an Average Return On Invested Capital over the past 3 years of 12.91%. This is in line with the industry average of 10.94%.
Industry RankSector Rank
ROA 6.19%
ROE 9.64%
ROIC 9.95%
ROA(3y)8.29%
ROA(5y)6.4%
ROE(3y)12.94%
ROE(5y)9.95%
ROIC(3y)12.91%
ROIC(5y)9.9%
PLAB Yearly ROA, ROE, ROICPLAB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10

1.3 Margins

PLAB has a Profit Margin of 12.67%. This is in the better half of the industry: PLAB outperforms 72.32% of its industry peers.
In the last couple of years the Profit Margin of PLAB has grown nicely.
With an excellent Operating Margin value of 24.75%, PLAB belongs to the best of the industry, outperforming 83.04% of the companies in the same industry.
PLAB's Operating Margin has improved in the last couple of years.
With a Gross Margin value of 35.81%, PLAB is not doing good in the industry: 64.29% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of PLAB has grown nicely.
Industry RankSector Rank
OM 24.75%
PM (TTM) 12.67%
GM 35.81%
OM growth 3Y21.48%
OM growth 5Y21.98%
PM growth 3Y21.78%
PM growth 5Y22.74%
GM growth 3Y13.15%
GM growth 5Y10.69%
PLAB Yearly Profit, Operating, Gross MarginsPLAB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

8

2. Health

2.1 Basic Checks

PLAB has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for PLAB has been increased compared to 1 year ago.
Compared to 5 years ago, PLAB has less shares outstanding
The debt/assets ratio for PLAB has been reduced compared to a year ago.
PLAB Yearly Shares OutstandingPLAB Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
PLAB Yearly Total Debt VS Total AssetsPLAB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

An Altman-Z score of 3.24 indicates that PLAB is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.24, PLAB is in line with its industry, outperforming 46.43% of the companies in the same industry.
PLAB has a debt to FCF ratio of 0.00. This is a very positive value and a sign of high solvency as it would only need 0.00 years to pay back of all of its debts.
The Debt to FCF ratio of PLAB (0.00) is better than 85.71% of its industry peers.
PLAB has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of PLAB (0.00) is better than 72.32% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 3.24
ROIC/WACC0.86
WACC11.52%
PLAB Yearly LT Debt VS Equity VS FCFPLAB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 4.99 indicates that PLAB has no problem at all paying its short term obligations.
PLAB's Current ratio of 4.99 is fine compared to the rest of the industry. PLAB outperforms 69.64% of its industry peers.
PLAB has a Quick Ratio of 4.62. This indicates that PLAB is financially healthy and has no problem in meeting its short term obligations.
PLAB has a better Quick ratio (4.62) than 77.68% of its industry peers.
Industry RankSector Rank
Current Ratio 4.99
Quick Ratio 4.62
PLAB Yearly Current Assets VS Current LiabilitesPLAB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

4

3. Growth

3.1 Past

The earnings per share for PLAB have decreased by -4.27% in the last year.
PLAB shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 33.90% yearly.
The Revenue has decreased by -1.79% in the past year.
The Revenue has been growing by 9.50% on average over the past years. This is quite good.
EPS 1Y (TTM)-4.27%
EPS 3Y32.05%
EPS 5Y33.9%
EPS Q2Q%0%
Revenue 1Y (TTM)-1.79%
Revenue growth 3Y9.31%
Revenue growth 5Y9.5%
Sales Q2Q%-0.28%

3.2 Future

The Earnings Per Share is expected to grow by 3.14% on average over the next years.
The Revenue is expected to grow by 2.37% on average over the next years.
EPS Next Y-3.08%
EPS Next 2Y1.66%
EPS Next 3Y3.14%
EPS Next 5YN/A
Revenue Next Year-2.73%
Revenue Next 2Y0.51%
Revenue Next 3Y2.37%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
PLAB Yearly Revenue VS EstimatesPLAB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M
PLAB Yearly EPS VS EstimatesPLAB Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5 2

7

4. Valuation

4.1 Price/Earnings Ratio

PLAB is valuated reasonably with a Price/Earnings ratio of 11.63.
Based on the Price/Earnings ratio, PLAB is valued cheaper than 99.11% of the companies in the same industry.
PLAB's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.55.
PLAB is valuated reasonably with a Price/Forward Earnings ratio of 11.49.
98.21% of the companies in the same industry are more expensive than PLAB, based on the Price/Forward Earnings ratio.
PLAB's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 23.04.
Industry RankSector Rank
PE 11.63
Fwd PE 11.49
PLAB Price Earnings VS Forward Price EarningsPLAB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of PLAB indicates a rather cheap valuation: PLAB is cheaper than 100.00% of the companies listed in the same industry.
PLAB's Price/Free Cash Flow ratio is rather cheap when compared to the industry. PLAB is cheaper than 85.71% of the companies in the same industry.
Industry RankSector Rank
P/FCF 21.51
EV/EBITDA 2.37
PLAB Per share dataPLAB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The decent profitability rating of PLAB may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.34
EPS Next 2Y1.66%
EPS Next 3Y3.14%

0

5. Dividend

5.1 Amount

No dividends for PLAB!.
Industry RankSector Rank
Dividend Yield N/A

PHOTRONICS INC

NASDAQ:PLAB (10/15/2025, 6:56:15 PM)

After market: 23.45 -0.05 (-0.21%)

23.5

+0.36 (+1.56%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)08-27 2025-08-27/bmo
Earnings (Next)12-09 2025-12-09/bmo
Inst Owners94.71%
Inst Owner Change-0.07%
Ins Owners4.15%
Ins Owner Change0.35%
Market Cap1.39B
Analysts84.44
Price Target33.64 (43.15%)
Short Float %4.63%
Short Ratio3.67
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)6.28%
Min EPS beat(2)-19.14%
Max EPS beat(2)31.69%
EPS beat(4)3
Avg EPS beat(4)8.06%
Min EPS beat(4)-19.14%
Max EPS beat(4)31.69%
EPS beat(8)4
Avg EPS beat(8)2.53%
EPS beat(12)6
Avg EPS beat(12)2.1%
EPS beat(16)9
Avg EPS beat(16)6.98%
Revenue beat(2)1
Avg Revenue beat(2)-0.82%
Min Revenue beat(2)-2.46%
Max Revenue beat(2)0.82%
Revenue beat(4)2
Avg Revenue beat(4)-0.62%
Min Revenue beat(4)-2.46%
Max Revenue beat(4)0.82%
Revenue beat(8)2
Avg Revenue beat(8)-2.81%
Revenue beat(12)4
Avg Revenue beat(12)-1.6%
Revenue beat(16)8
Avg Revenue beat(16)-0.57%
PT rev (1m)1.33%
PT rev (3m)5.66%
EPS NQ rev (1m)1.72%
EPS NQ rev (3m)9.12%
EPS NY rev (1m)9.66%
EPS NY rev (3m)9.66%
Revenue NQ rev (1m)0.34%
Revenue NQ rev (3m)-1.51%
Revenue NY rev (1m)0.08%
Revenue NY rev (3m)0.32%
Valuation
Industry RankSector Rank
PE 11.63
Fwd PE 11.49
P/S 1.62
P/FCF 21.51
P/OCF 6.07
P/B 1.23
P/tB 1.23
EV/EBITDA 2.37
EPS(TTM)2.02
EY8.6%
EPS(NY)2.05
Fwd EY8.71%
FCF(TTM)1.09
FCFY4.65%
OCF(TTM)3.87
OCFY16.47%
SpS14.51
BVpS19.08
TBVpS19.08
PEG (NY)N/A
PEG (5Y)0.34
Profitability
Industry RankSector Rank
ROA 6.19%
ROE 9.64%
ROCE 13.43%
ROIC 9.95%
ROICexc 15.68%
ROICexgc 15.68%
OM 24.75%
PM (TTM) 12.67%
GM 35.81%
FCFM 7.53%
ROA(3y)8.29%
ROA(5y)6.4%
ROE(3y)12.94%
ROE(5y)9.95%
ROIC(3y)12.91%
ROIC(5y)9.9%
ROICexc(3y)20.57%
ROICexc(5y)15.24%
ROICexgc(3y)20.57%
ROICexgc(5y)15.24%
ROCE(3y)17.42%
ROCE(5y)13.37%
ROICexcg growth 3Y30.41%
ROICexcg growth 5Y29.52%
ROICexc growth 3Y30.45%
ROICexc growth 5Y29.79%
OM growth 3Y21.48%
OM growth 5Y21.98%
PM growth 3Y21.78%
PM growth 5Y22.74%
GM growth 3Y13.15%
GM growth 5Y10.69%
F-Score5
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 203.77%
Cap/Sales 19.14%
Interest Coverage 250
Cash Conversion 78.12%
Profit Quality 59.42%
Current Ratio 4.99
Quick Ratio 4.62
Altman-Z 3.24
F-Score5
WACC11.52%
ROIC/WACC0.86
Cap/Depr(3y)153.58%
Cap/Depr(5y)131.47%
Cap/Sales(3y)14.5%
Cap/Sales(5y)14.32%
Profit Quality(3y)124.28%
Profit Quality(5y)132.15%
High Growth Momentum
Growth
EPS 1Y (TTM)-4.27%
EPS 3Y32.05%
EPS 5Y33.9%
EPS Q2Q%0%
EPS Next Y-3.08%
EPS Next 2Y1.66%
EPS Next 3Y3.14%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.79%
Revenue growth 3Y9.31%
Revenue growth 5Y9.5%
Sales Q2Q%-0.28%
Revenue Next Year-2.73%
Revenue Next 2Y0.51%
Revenue Next 3Y2.37%
Revenue Next 5YN/A
EBIT growth 1Y-8.07%
EBIT growth 3Y32.79%
EBIT growth 5Y33.57%
EBIT Next Year26.03%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-50.42%
FCF growth 3Y46.47%
FCF growth 5YN/A
OCF growth 1Y-16.94%
OCF growth 3Y20.13%
OCF growth 5Y30.76%